What percentage of Americans are extremely worried about the nation’s healthcare system? Will this year’s flu be as bad as 2018? Is value-based care catching on or fading away? Find the answers to these questions and more in The Rundown, our weekly digest of healthcare’s most important issues!
Tag Archives: value-based care
2018 was an exciting year for healthcare: multibillion-dollar companies merged, telehealth laws advanced, and disruptive innovators like Amazon made a splash. With all of this activity, what trends and technology can we look forward to in 2019?
In part five of our “Peak Practice Performance” series, we examine how primary care providers can leverage “pop health” initiatives like wellness visits, Medicare Advantage, telehealth, and other strategies to boost their revenue and improve patient health outcomes!
Physician-led ACOs routinely outperform hospital ACOs. Why is this? Learn what policies and features enable these organizations to improve the patient experience while lowering costs!
Clunky technology and administrative hassles force providers to exert herculean energy to discover basic data about their practices. How many diabetics do you treat at your practice? How many non-smokers? What about patients with more than one chronic illness? Understanding the nuances of your patient population is important to you because you care about the …
By now, you’ve heard about the transition from volume to value in healthcare, but what does it really mean? In this blog, I’ll attempt to explain it in layman’s terms. Value-based Care and the Connection with Population Health Simply put, “value” is defined as better quality for lower cost; an easy concept to grasp, but …
According to a recently issued American Medical Association study, the number of independent doctors has declined in the period between 2012 to 2016, leaving fewer than 47.1% of physicians with ownership stakes in a medical practice. Yet, in a recently issued survey conducted by Medscape, market analysts say they expect private practices will remain a …
Everyone is talking about outrageous drug prices: $44,000 for Olysio, a drug used to treat Hepatitis C; $51,600 for HP Acthar, a gel that treats multiple sclerosis; $1,000 per pill for Sovaldi, another Hepatitis C drug, which amounts to a whopping $84,000 for a full 12-week course treatment. The tides on drug prices may soon be …
Healthcare is a rapidly evolving industry – it’s difficult to read up on everything that matters to you. But the success of your practice can depend on how knowledgeable you are about changes in the healthcare landscape. Privia has compiled a weekly list of important articles we are reading on healthcare industry trends, clinical best …